Global and Japan Cancer Biopsy Market Size, Status and Forecast 2024-2031

Report ID: 1024269 | Published Date: Nov 2024 | No. of Page: 115 | Base Year: 2023 | Rating: 4.8 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Cancer Biopsy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Tissue Biopsies
        1.2.3 Liquid Biopsies
        1.2.4 Others
    1.3 Market by Application
        1.3.1 Global Cancer Biopsy Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Breast Cancer
        1.3.3 Colorectal Cancer
        1.3.4 Cervical Cancers
        1.3.5 Lung Cancers
        1.3.6 Prostate Cancers
        1.3.7 Skin Cancers
        1.3.8 Blood Cancers
        1.3.9 Kidney Cancers
        1.3.10 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Cancer Biopsy Market Perspective (2016-2027)
    2.2 Cancer Biopsy Growth Trends by Regions
        2.2.1 Cancer Biopsy Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Cancer Biopsy Historic Market Share by Regions (2016-2021)
        2.2.3 Cancer Biopsy Forecasted Market Size by Regions (2022-2027)
    2.3 Cancer Biopsy Industry Dynamic
        2.3.1 Cancer Biopsy Market Trends
        2.3.2 Cancer Biopsy Market Drivers
        2.3.3 Cancer Biopsy Market Challenges
        2.3.4 Cancer Biopsy Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Cancer Biopsy Players by Revenue
        3.1.1 Global Top Cancer Biopsy Players by Revenue (2016-2021)
        3.1.2 Global Cancer Biopsy Revenue Market Share by Players (2016-2021)
    3.2 Global Cancer Biopsy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Cancer Biopsy Revenue
    3.4 Global Cancer Biopsy Market Concentration Ratio
        3.4.1 Global Cancer Biopsy Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Cancer Biopsy Revenue in 2020
    3.5 Cancer Biopsy Key Players Head office and Area Served
    3.6 Key Players Cancer Biopsy Product Solution and Service
    3.7 Date of Enter into Cancer Biopsy Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Cancer Biopsy Breakdown Data by Type
    4.1 Global Cancer Biopsy Historic Market Size by Type (2016-2021)
    4.2 Global Cancer Biopsy Forecasted Market Size by Type (2022-2027)

5 Cancer Biopsy Breakdown Data by Application
    5.1 Global Cancer Biopsy Historic Market Size by Application (2016-2021)
    5.2 Global Cancer Biopsy Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Cancer Biopsy Market Size (2016-2027)
    6.2 North America Cancer Biopsy Market Size by Type
        6.2.1 North America Cancer Biopsy Market Size by Type (2016-2021)
        6.2.2 North America Cancer Biopsy Market Size by Type (2022-2027)
        6.2.3 North America Cancer Biopsy Market Size by Type (2016-2027)
    6.3 North America Cancer Biopsy Market Size by Application
        6.3.1 North America Cancer Biopsy Market Size by Application (2016-2021)
        6.3.2 North America Cancer Biopsy Market Size by Application (2022-2027)
        6.3.3 North America Cancer Biopsy Market Size by Application (2016-2027)
    6.4 North America Cancer Biopsy Market Size by Country
        6.4.1 North America Cancer Biopsy Market Size by Country (2016-2021)
        6.4.2 North America Cancer Biopsy Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Cancer Biopsy Market Size (2016-2027)
    7.2 Europe Cancer Biopsy Market Size by Type
        7.2.1 Europe Cancer Biopsy Market Size by Type (2016-2021)
        7.2.2 Europe Cancer Biopsy Market Size by Type (2022-2027)
        7.2.3 Europe Cancer Biopsy Market Size by Type (2016-2027)
    7.3 Europe Cancer Biopsy Market Size by Application
        7.3.1 Europe Cancer Biopsy Market Size by Application (2016-2021)
        7.3.2 Europe Cancer Biopsy Market Size by Application (2022-2027)
        7.3.3 Europe Cancer Biopsy Market Size by Application (2016-2027)
    7.4 Europe Cancer Biopsy Market Size by Country
        7.4.1 Europe Cancer Biopsy Market Size by Country (2016-2021)
        7.4.2 Europe Cancer Biopsy Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Cancer Biopsy Market Size (2016-2027)
    8.2 Asia-Pacific Cancer Biopsy Market Size by Type
        8.2.1 Asia-Pacific Cancer Biopsy Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Cancer Biopsy Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Cancer Biopsy Market Size by Type (2016-2027)
    8.3 Asia-Pacific Cancer Biopsy Market Size by Application
        8.3.1 Asia-Pacific Cancer Biopsy Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Cancer Biopsy Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Cancer Biopsy Market Size by Application (2016-2027)
    8.4 Asia-Pacific Cancer Biopsy Market Size by Region
        8.4.1 Asia-Pacific Cancer Biopsy Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Cancer Biopsy Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Cancer Biopsy Market Size (2016-2027)
    9.2 Latin America Cancer Biopsy Market Size by Type
        9.2.1 Latin America Cancer Biopsy Market Size by Type (2016-2021)
        9.2.2 Latin America Cancer Biopsy Market Size by Type (2022-2027)
        9.2.3 Latin America Cancer Biopsy Market Size by Type (2016-2027)
    9.3 Latin America Cancer Biopsy Market Size by Application
        9.3.1 Latin America Cancer Biopsy Market Size by Application (2016-2021)
        9.3.2 Latin America Cancer Biopsy Market Size by Application (2022-2027)
        9.3.3 Latin America Cancer Biopsy Market Size by Application (2016-2027)
    9.4 Latin America Cancer Biopsy Market Size by Country
        9.4.1 Latin America Cancer Biopsy Market Size by Country (2016-2021)
        9.4.2 Latin America Cancer Biopsy Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Cancer Biopsy Market Size (2016-2027)
    10.2 Middle East & Africa Cancer Biopsy Market Size by Type
        10.2.1 Middle East & Africa Cancer Biopsy Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Cancer Biopsy Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Cancer Biopsy Market Size by Type (2016-2027)
    10.3 Middle East & Africa Cancer Biopsy Market Size by Application
        10.3.1 Middle East & Africa Cancer Biopsy Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Cancer Biopsy Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Cancer Biopsy Market Size by Application (2016-2027)
    10.4 Middle East & Africa Cancer Biopsy Market Size by Country
        10.4.1 Middle East & Africa Cancer Biopsy Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Cancer Biopsy Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Qiagen N.V.
        11.1.1 Qiagen N.V. Company Details
        11.1.2 Qiagen N.V. Business Overview
        11.1.3 Qiagen N.V. Cancer Biopsy Introduction
        11.1.4 Qiagen N.V. Revenue in Cancer Biopsy Business (2016-2021)
        11.1.5 Qiagen N.V. Recent Development
    11.2 Illumina, Inc.
        11.2.1 Illumina, Inc. Company Details
        11.2.2 Illumina, Inc. Business Overview
        11.2.3 Illumina, Inc. Cancer Biopsy Introduction
        11.2.4 Illumina, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.2.5 Illumina, Inc. Recent Development
    11.3 ANGLE Plc
        11.3.1 ANGLE Plc Company Details
        11.3.2 ANGLE Plc Business Overview
        11.3.3 ANGLE Plc Cancer Biopsy Introduction
        11.3.4 ANGLE Plc Revenue in Cancer Biopsy Business (2016-2021)
        11.3.5 ANGLE Plc Recent Development
    11.4 Myriad Genetics
        11.4.1 Myriad Genetics Company Details
        11.4.2 Myriad Genetics Business Overview
        11.4.3 Myriad Genetics Cancer Biopsy Introduction
        11.4.4 Myriad Genetics Revenue in Cancer Biopsy Business (2016-2021)
        11.4.5 Myriad Genetics Recent Development
    11.5 Hologic, Inc.
        11.5.1 Hologic, Inc. Company Details
        11.5.2 Hologic, Inc. Business Overview
        11.5.3 Hologic, Inc. Cancer Biopsy Introduction
        11.5.4 Hologic, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.5.5 Hologic, Inc. Recent Development
    11.6 Biocept, Inc.
        11.6.1 Biocept, Inc. Company Details
        11.6.2 Biocept, Inc. Business Overview
        11.6.3 Biocept, Inc. Cancer Biopsy Introduction
        11.6.4 Biocept, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.6.5 Biocept, Inc. Recent Development
    11.7 Thermo Fisher Scientific, Inc.
        11.7.1 Thermo Fisher Scientific, Inc. Company Details
        11.7.2 Thermo Fisher Scientific, Inc. Business Overview
        11.7.3 Thermo Fisher Scientific, Inc. Cancer Biopsy Introduction
        11.7.4 Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.7.5 Thermo Fisher Scientific, Inc. Recent Development
    11.8 Danaher
        11.8.1 Danaher Company Details
        11.8.2 Danaher Business Overview
        11.8.3 Danaher Cancer Biopsy Introduction
        11.8.4 Danaher Revenue in Cancer Biopsy Business (2016-2021)
        11.8.5 Danaher Recent Development
    11.9 Lucence Diagnostics Pte. Ltd.
        11.9.1 Lucence Diagnostics Pte. Ltd. Company Details
        11.9.2 Lucence Diagnostics Pte. Ltd. Business Overview
        11.9.3 Lucence Diagnostics Pte. Ltd. Cancer Biopsy Introduction
        11.9.4 Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2016-2021)
        11.9.5 Lucence Diagnostics Pte. Ltd. Recent Development
    11.10 GRAIL, Inc.
        11.10.1 GRAIL, Inc. Company Details
        11.10.2 GRAIL, Inc. Business Overview
        11.10.3 GRAIL, Inc. Cancer Biopsy Introduction
        11.10.4 GRAIL, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.10.5 GRAIL, Inc. Recent Development
    11.11 Guardant Health
        11.11.1 Guardant Health Company Details
        11.11.2 Guardant Health Business Overview
        11.11.3 Guardant Health Cancer Biopsy Introduction
        11.11.4 Guardant Health Revenue in Cancer Biopsy Business (2016-2021)
        11.11.5 Guardant Health Recent Development
    11.12 Exact Sciences Corporation
        11.12.1 Exact Sciences Corporation Company Details
        11.12.2 Exact Sciences Corporation Business Overview
        11.12.3 Exact Sciences Corporation Cancer Biopsy Introduction
        11.12.4 Exact Sciences Corporation Revenue in Cancer Biopsy Business (2016-2021)
        11.12.5 Exact Sciences Corporation Recent Development
    11.13 Freenome Holdings, Inc.
        11.13.1 Freenome Holdings, Inc. Company Details
        11.13.2 Freenome Holdings, Inc. Business Overview
        11.13.3 Freenome Holdings, Inc. Cancer Biopsy Introduction
        11.13.4 Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.13.5 Freenome Holdings, Inc. Recent Development
    11.14 Oncimmune
        11.14.1 Oncimmune Company Details
        11.14.2 Oncimmune Business Overview
        11.14.3 Oncimmune Cancer Biopsy Introduction
        11.14.4 Oncimmune Revenue in Cancer Biopsy Business (2016-2021)
        11.14.5 Oncimmune Recent Development
    11.15 Chronix Biomedical, Inc.
        11.15.1 Chronix Biomedical, Inc. Company Details
        11.15.2 Chronix Biomedical, Inc. Business Overview
        11.15.3 Chronix Biomedical, Inc. Cancer Biopsy Introduction
        11.15.4 Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.15.5 Chronix Biomedical, Inc. Recent Development
    11.16 Personal Genome Diagnostics Inc.
        11.16.1 Personal Genome Diagnostics Inc. Company Details
        11.16.2 Personal Genome Diagnostics Inc. Business Overview
        11.16.3 Personal Genome Diagnostics Inc. Cancer Biopsy Introduction
        11.16.4 Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2016-2021)
        11.16.5 Personal Genome Diagnostics Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Cancer Biopsy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Tissue Biopsies
    Table 3. Key Players of Liquid Biopsies
    Table 4. Key Players of Others
    Table 5. Global Cancer Biopsy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 6. Global Cancer Biopsy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Cancer Biopsy Market Size by Regions (2016-2021) & (US$ Million)
    Table 8. Global Cancer Biopsy Market Share by Regions (2016-2021)
    Table 9. Global Cancer Biopsy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 10. Global Cancer Biopsy Market Share by Regions (2022-2027)
    Table 11. Cancer Biopsy Market Trends
    Table 12. Cancer Biopsy Market Drivers
    Table 13. Cancer Biopsy Market Challenges
    Table 14. Cancer Biopsy Market Restraints
    Table 15. Global Cancer Biopsy Revenue by Players (2016-2021) & (US$ Million)
    Table 16. Global Cancer Biopsy Market Share by Players (2016-2021)
    Table 17. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopsy as of 2020)
    Table 18. Ranking of Global Top Cancer Biopsy Companies by Revenue (US$ Million) in 2020
    Table 19. Global 5 Largest Players Market Share by Cancer Biopsy Revenue (CR5 and HHI) & (2016-2021)
    Table 20. Key Players Headquarters and Area Served
    Table 21. Key Players Cancer Biopsy Product Solution and Service
    Table 22. Date of Enter into Cancer Biopsy Market
    Table 23. Mergers & Acquisitions, Expansion Plans
    Table 24. Global Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 25. Global Cancer Biopsy Revenue Market Share by Type (2016-2021)
    Table 26. Global Cancer Biopsy Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 27. Global Cancer Biopsy Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 28. Global Cancer Biopsy Market Size Share by Application (2016-2021) & (US$ Million)
    Table 29. Global Cancer Biopsy Revenue Market Share by Application (2016-2021)
    Table 30. Global Cancer Biopsy Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 31. Global Cancer Biopsy Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 32. North America Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 33. North America Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
    Table 34. North America Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
    Table 35. North America Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
    Table 36. North America Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million) 
    Table 37. North America Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million) 
    Table 38. Europe Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 39. Europe Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
    Table 40. Europe Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
    Table 41. Europe Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
    Table 42. Europe Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million) 
    Table 43. Europe Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million) 
    Table 44. Asia-Pacific Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 45. Asia-Pacific Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
    Table 46. Asia-Pacific Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
    Table 47. Asia-Pacific Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
    Table 48. Asia-Pacific Cancer Biopsy Market Size by Region (2016-2021) & (US$ Million) 
    Table 49. Asia-Pacific Cancer Biopsy Market Size by Region (2022-2027) & (US$ Million) 
    Table 50. Latin America Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 51. Latin America Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
    Table 52. Latin America Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
    Table 53. Latin America Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
    Table 54. Latin America Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million) 
    Table 55. Latin America Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million) 
    Table 56. Middle East & Africa Cancer Biopsy Market Size by Type (2016-2021) (US$ Million)
    Table 57. Middle East & Africa Cancer Biopsy Market Size by Type (2022-2027) & (US$ Million)
    Table 58. Middle East & Africa Cancer Biopsy Market Size by Application (2016-2021) (US$ Million)
    Table 59. Middle East & Africa Cancer Biopsy Market Size by Application (2022-2027) & (US$ Million)
    Table 60. Middle East & Africa Cancer Biopsy Market Size by Country (2016-2021) & (US$ Million) 
    Table 61. Middle East & Africa Cancer Biopsy Market Size by Country (2022-2027) & (US$ Million) 
    Table 62. Qiagen N.V. Company Details
    Table 63. Qiagen N.V. Business Overview
    Table 64. Qiagen N.V. Cancer Biopsy Product
    Table 65. Qiagen N.V. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 66. Qiagen N.V. Recent Development
    Table 67. Illumina, Inc. Company Details
    Table 68. Illumina, Inc. Business Overview
    Table 69. Illumina, Inc. Cancer Biopsy Product
    Table 70. Illumina, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 71. Illumina, Inc. Recent Development
    Table 72. ANGLE Plc Company Details
    Table 73. ANGLE Plc Business Overview
    Table 74. ANGLE Plc Cancer Biopsy Product
    Table 75. ANGLE Plc Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 76. ANGLE Plc Recent Development
    Table 77. Myriad Genetics Company Details
    Table 78. Myriad Genetics Business Overview
    Table 79. Myriad Genetics Cancer Biopsy Product
    Table 80. Myriad Genetics Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 81. Myriad Genetics Recent Development
    Table 82. Hologic, Inc. Company Details
    Table 83. Hologic, Inc. Business Overview
    Table 84. Hologic, Inc. Cancer Biopsy Product
    Table 85. Hologic, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 86. Hologic, Inc. Recent Development
    Table 87. Biocept, Inc. Company Details
    Table 88. Biocept, Inc. Business Overview
    Table 89. Biocept, Inc. Cancer Biopsy Product
    Table 90. Biocept, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 91. Biocept, Inc. Recent Development
    Table 92. Thermo Fisher Scientific, Inc. Company Details
    Table 93. Thermo Fisher Scientific, Inc. Business Overview
    Table 94. Thermo Fisher Scientific, Inc. Cancer Biopsy Product
    Table 95. Thermo Fisher Scientific, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 96. Thermo Fisher Scientific, Inc. Recent Development
    Table 97. Danaher Company Details
    Table 98. Danaher Business Overview
    Table 99. Danaher Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 100. Danaher Recent Development
    Table 101. Lucence Diagnostics Pte. Ltd. Company Details
    Table 102. Lucence Diagnostics Pte. Ltd. Business Overview
    Table 103. Lucence Diagnostics Pte. Ltd. Cancer Biopsy Product
    Table 104. Lucence Diagnostics Pte. Ltd. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 105. Lucence Diagnostics Pte. Ltd. Recent Development
    Table 106. GRAIL, Inc. Company Details
    Table 107. GRAIL, Inc. Business Overview
    Table 108. GRAIL, Inc. Cancer Biopsy Product
    Table 109. GRAIL, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 110. GRAIL, Inc. Recent Development
    Table 111. Guardant Health Company Details
    Table 112. Guardant Health Business Overview
    Table 113. Guardant Health Cancer Biopsy Product
    Table 114. Guardant Health Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 115. Guardant Health Recent Development
    Table 116. Exact Sciences Corporation Company Details
    Table 117. Exact Sciences Corporation Business Overview
    Table 118. Exact Sciences Corporation Cancer Biopsy Product
    Table 119. Exact Sciences Corporation Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 120. Exact Sciences Corporation Recent Development
    Table 121. Freenome Holdings, Inc. Company Details
    Table 122. Freenome Holdings, Inc. Business Overview
    Table 123. Freenome Holdings, Inc. Cancer Biopsy Product
    Table 124. Freenome Holdings, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 125. Freenome Holdings, Inc. Recent Development
    Table 126. Oncimmune Company Details
    Table 127. Oncimmune Business Overview
    Table 128. Oncimmune Cancer Biopsy Product
    Table 129. Oncimmune Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 130. Oncimmune Recent Development
    Table 131. Chronix Biomedical, Inc. Company Details
    Table 132. Chronix Biomedical, Inc. Business Overview
    Table 133. Chronix Biomedical, Inc. Cancer Biopsy Product
    Table 134. Chronix Biomedical, Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 135. Chronix Biomedical, Inc. Recent Development
    Table 136. Personal Genome Diagnostics Inc. Company Details
    Table 137. Personal Genome Diagnostics Inc. Business Overview
    Table 138. Personal Genome Diagnostics Inc. Cancer Biopsy Product
    Table 139. Personal Genome Diagnostics Inc. Revenue in Cancer Biopsy Business (2016-2021) & (US$ Million)
    Table 140. Personal Genome Diagnostics Inc. Recent Development
    Table 141. Research Programs/Design for This Report
    Table 142. Key Data Information from Secondary Sources
    Table 143. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Cancer Biopsy Market Share by Type: 2020 VS 2027
    Figure 2. Tissue Biopsies Features
    Figure 3. Liquid Biopsies Features
    Figure 4. Others Features
    Figure 5. Global Cancer Biopsy Market Share by Application: 2020 VS 2027
    Figure 6. Breast Cancer Case Studies
    Figure 7. Colorectal Cancer Case Studies
    Figure 8. Cervical Cancers Case Studies
    Figure 9. Lung Cancers Case Studies
    Figure 10. Prostate Cancers Case Studies
    Figure 11. Skin Cancers Case Studies
    Figure 12. Blood Cancers Case Studies
    Figure 13. Kidney Cancers Case Studies
    Figure 14. Others Case Studies
    Figure 15. Cancer Biopsy Report Years Considered
    Figure 16. Global Cancer Biopsy Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 17. Global Cancer Biopsy Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 18. Global Cancer Biopsy Market Share by Regions: 2020 VS 2027
    Figure 19. Global Cancer Biopsy Market Share by Regions (2022-2027)
    Figure 20. Global Cancer Biopsy Market Share by Players in 2020
    Figure 21. Global Top Cancer Biopsy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Cancer Biopsy as of 2020
    Figure 22. The Top 10 and 5 Players Market Share by Cancer Biopsy Revenue in 2020
    Figure 23. Global Cancer Biopsy Revenue Market Share by Type (2016-2021)
    Figure 24. Global Cancer Biopsy Revenue Market Share by Type (2022-2027)
    Figure 25. North America Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. North America Cancer Biopsy Market Share by Type (2016-2027)
    Figure 27. North America Cancer Biopsy Market Share by Application (2016-2027)
    Figure 28. North America Cancer Biopsy Market Share by Country (2016-2027)
    Figure 29. United States Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 30. Canada Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. Europe Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. Europe Cancer Biopsy Market Share by Type (2016-2027)
    Figure 33. Europe Cancer Biopsy Market Share by Application (2016-2027)
    Figure 34. Europe Cancer Biopsy Market Share by Country (2016-2027)
    Figure 35. Germany Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. France Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. U.K. Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 38. Italy Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 39. Russia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 40. Nordic Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Asia-Pacific Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. Asia-Pacific Cancer Biopsy Market Share by Type (2016-2027)
    Figure 43. Asia-Pacific Cancer Biopsy Market Share by Application (2016-2027)
    Figure 44. Asia-Pacific Cancer Biopsy Market Share by Region (2016-2027)
    Figure 45. China Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Japan Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. South Korea Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 48. Southeast Asia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 49. India Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 50. Australia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Latin America Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Latin America Cancer Biopsy Market Share by Type (2016-2027)
    Figure 53. Latin America Cancer Biopsy Market Share by Application (2016-2027)
    Figure 54. Latin America Cancer Biopsy Market Share by Country (2016-2027)
    Figure 55. Mexico Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 56. Brazil Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Middle East & Africa Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. Middle East & Africa Cancer Biopsy Market Share by Type (2016-2027)
    Figure 59. Middle East & Africa Cancer Biopsy Market Share by Application (2016-2027)
    Figure 60. Middle East & Africa Cancer Biopsy Market Share by Country (2016-2027)
    Figure 61. Turkey Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 62. Saudi Arabia Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 63. UAE Cancer Biopsy Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 64. Qiagen N.V. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 65. Illumina, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 66. ANGLE Plc Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 67. Myriad Genetics Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 68. Hologic, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 69. Biocept, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 70. Thermo Fisher Scientific, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 71. Danaher Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 72. Lucence Diagnostics Pte. Ltd. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 73. GRAIL, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 74. Guardant Health Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 75. Exact Sciences Corporation Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 76. Freenome Holdings, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 77. Oncimmune Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 78. Chronix Biomedical, Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 79. Personal Genome Diagnostics Inc. Revenue Growth Rate in Cancer Biopsy Business (2016-2021)
    Figure 80. Bottom-up and Top-down Approaches for This Report
    Figure 81. Data Triangulation
    Figure 82. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Qiagen N.V.
Illumina, Inc.
ANGLE Plc
Myriad Genetics
Hologic, Inc.
Biocept, Inc.
Thermo Fisher Scientific, Inc.
Danaher
Lucence Diagnostics Pte. Ltd.
GRAIL, Inc.
Guardant Health
Exact Sciences Corporation
Freenome Holdings, Inc.
Oncimmune
Chronix Biomedical, Inc.
Personal Genome Diagnostics Inc.
Frequently Asked Questions
Cancer Biopsy report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Cancer Biopsy report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Cancer Biopsy report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Transplant Box

Transplant Box market is segmented by region (country), players, by Type, and by Application. Pla ... Read More

Syndesmosis Implant

Syndesmosis Implant market is segmented by region (country), players, by Type, and by Application ... Read More